We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+37.16%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$24.7M
Cap. Flow
-$21.5M
Cap. Flow %
-11.74%
Top 10 Hldgs %
60.99%
Holding
128
New
6
Increased
17
Reduced
11
Closed
35
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$7.51M
2
KW icon
Kennedy-Wilson Holdings
KW
+$3.02M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.72M
4
ZGNX
Zogenix, Inc.
ZGNX
+$1.46M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.35M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$8.13M
2
BRSL icon
Brightstar Lottery PLC
BRSL
+$3.9M
3
APO icon
Apollo Global Management
APO
+$3.18M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.1M
5
FNM.PRT
FEDERAL NATL MTG ASS 08250
FNM.PRT
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 45.06%
2 Financials 16.44%
3 Industrials 13.2%
4 Technology 8.55%
5 Communication Services 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RHP icon
51
Ryman Hospitality Properties
RHP
$8.69B
$429K 0.23%
12,400
– –
2013 Q2
28 quarters
WPC icon
52
W.P. Carey
WPC
$14.8B
$406K 0.22%
6,126
– –
2017 Q3
11 quarters
MIC icon
53
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$403K 0.22%
13,150
– –
2014 Q2
24 quarters
AAPL icon
54
Apple
AAPL
$5.01T
$384K 0.21%
4,200
– –
2013 Q2
28 quarters
DELL icon
55
Dell
DELL
$287B
$353K 0.19%
12,678
– –
2018 Q2
8 quarters
CAG icon
56
Conagra Brands
CAG
$6.91B
$352K 0.19%
10,000
– –
2017 Q3
11 quarters
CTVA icon
57
Corteva
CTVA
$8.59B
$336K 0.18%
12,545
– –
2019 Q2
4 quarters
KRYS icon
58
Krystal Biotech
KRYS
$9.37B
$293K 0.16%
7,079
– –
2018 Q4
6 quarters
MSFT icon
59
Microsoft
MSFT
$3.93T
$285K 0.16%
1,400
– –
2013 Q2
28 quarters
TGTX icon
60
TG Therapeutics
TGTX
$8.26B
$234K 0.13%
+12,000
New +$193K
2020 Q2
0 quarters
CYTK icon
61
Cytokinetics
CYTK
$8.61B
$210K 0.11%
+8,923
New +$167K
2020 Q2
0 quarters
CPRX icon
62
DELISTED
Catalyst Pharmaceutical
CPRX
$195K 0.11%
42,117
-11,000
-21% -$49.4K
2017 Q1
13 quarters
VRCA icon
63
Verrica Pharmaceuticals
VRCA
$61.8M
$165K 0.09%
1,495
+20
+1% +$2.31K
2019 Q2
4 quarters
FSBW icon
64
FS Bancorp
FSBW
$353M
$138K 0.08%
7,154
– –
2018 Q4
6 quarters
GMED icon
65
Globus Medical
GMED
$10.3B
$138K 0.08%
2,900
– –
2019 Q1
5 quarters
KHC icon
66
The Kraft Heinz Company
KHC
$28.1B
$135K 0.07%
4,234
– –
2015 Q3
19 quarters
RLMD icon
67
Relmada Therapeutics
RLMD
$331M
$134K 0.07%
+3,000
New +$127K
2020 Q2
0 quarters
LEGH icon
68
Legacy Housing
LEGH
$651M
$128K 0.07%
9,000
– –
2018 Q4
6 quarters
TARA icon
69
Protara Therapeutics
TARA
$137M
$112K 0.06%
3,835
+1,200
+46% +$37.1K
2020 Q1
1 quarter
TTE icon
70
TotalEnergies
TTE
$201B
$110K 0.06%
2,860
– –
2013 Q2
28 quarters
CUZ icon
71
Cousins Properties
CUZ
$4.55B
$100K 0.05%
3,357
– –
2015 Q1
21 quarters
SSB icon
72
SouthState Bank Corp
SSB
$9.9B
$99K 0.05%
+2,082
New +$109K
2020 Q2
0 quarters
VLY icon
73
Valley National Bancorp
VLY
$7B
$98K 0.05%
12,480
– –
2019 Q4
2 quarters
MDT icon
74
Medtronic
MDT
$121B
$96K 0.05%
1,050
– –
2014 Q3
23 quarters
FNB icon
75
FNB Corp
FNB
$6.13B
$67K 0.04%
8,905
– –
2014 Q3
23 quarters
1 2
3
4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2020 Portfolio in Review

As of Q2 2020, David M. Knott held 128 positions worth $183M, up 16% from $158M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

David M. Knott withdrew a net $21.5M in Q2 2020, closing 35 positions and reducing 11 holdings. Its most notable exit was FEDERAL NATL MTG ASS 08250, an estimated $2.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Financials and Industrials.

Against the trend, David M. Knott opened a new position in FTAI Aviation worth $9.09M.

  • David M. Knott's largest Q2 2020 buy was FTAI Aviation: 819,700 shares worth $9.09M.
  • David M. Knott added most to Aurinia Pharmaceuticals in Q2 2020, an estimated $1.72M increase.
  • David M. Knott's biggest Q2 2020 reduction was Ligand Pharmaceuticals, cutting an estimated $8.13M.
  • David M. Knott fully exited FEDERAL NATL MTG ASS 08250 in Q2 2020, selling an estimated $2.19M.
  • David M. Knott's ten largest holdings make up 61% of its $183M portfolio in Q2 2020.
  • David M. Knott opened 6 new positions and closed 35 in Q2 2020.
  • David M. Knott's portfolio value rose 16% quarter-over-quarter to $183M.

Based on David M. Knott's 13F filing for Q2 2020, filed 12 Aug 2020.